How a joined-up development strategy pays off for early-stage biotechs
Parexel Biotech’s Nate Akers and Vicky Hsu discuss how important it is for biotechs to align clinical execution with a clearly defined regulatory strategy to increase the chance of success for a new drug program.
Related Insights
Article
Near-term strategies for biotech drug developers facing shifting healthcare dynamics
Feb 14, 2024
Video
How to transition existing trials under EU-CTR
Feb 1, 2023
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Webinar
Regulatory roadmap for biotechs: Effective strategies for streamlined early phase development
May 6, 2025
Playbook
Streamlining development in the EU: Strategies for smoother CTA submissions
Feb 27, 2025
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Blog
Overcoming risks in Phase 3 trials to accelerate time to market
Jan 22, 2025
Webinar
Accelerated Early Phase Decision-Making – Insider Insights to Speed Development
Jan 7, 2025
Blog
Focusing on value drivers to reduce risk in early-stage drug development
Jan 6, 2025
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Related Insights
Article
Near-term strategies for biotech drug developers facing shifting healthcare dynamics
Feb 14, 2024
Video
How to transition existing trials under EU-CTR
Feb 1, 2023
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Webinar
Regulatory roadmap for biotechs: Effective strategies for streamlined early phase development
May 6, 2025
Playbook
Streamlining development in the EU: Strategies for smoother CTA submissions
Feb 27, 2025
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Blog
Overcoming risks in Phase 3 trials to accelerate time to market
Jan 22, 2025
Webinar
Accelerated Early Phase Decision-Making – Insider Insights to Speed Development
Jan 7, 2025
Blog
Focusing on value drivers to reduce risk in early-stage drug development
Jan 6, 2025
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021